chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported at her booster dose that she had chest pressure 10hrs post vaccination.  Pt did not seek medical care for this reaction.
As per to mom, patient started feeling weakness and palpitations around 11pm the same day of the vaccine. After 5 days mom bough him to the clinic saw PA, sent him foe a EKG at the hospital and referral to a Cardiologist . The vaccine took place at pharmacy .
Pt developed delayed bilateral upper eye lid swelling and lower eye lid eczema like rash lasted for 3-4 days. Eyes are slightly painful the first few days and gradually resolve.
01/06/21 at 6 pm, body aches, and chills  01/07/21 at 12am T102.2, SPO2 62% on room air. Was sent to ER and returned. 01/08/21 at SPO@ less then 60% on room air, non responsive to verbal tactile stimuli. Responsive to sternal rub only.  Was sent to ER and admitted to ICU.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 25-AUG-2015, the patient was vaccinated with the first dose of GARDASIL 0.5 ml, intramuscularly (lot #, expiration date were not reported). At the time of the report the patient was in the pharmacy to be administered the second dose of the series and would be administered GARDASIL 9 0.5 ml, intramuscularly, lot # L006406, expiration date 24-FEB-2017. No adverse effects reported. Additional information has been requested.
has been loosing her balance; can't lift her arm; area of injection is still sore and swollen; pain and soreness; This spontaneous report was received from an 87-year-old female patient reporting on herself. The patient's weight was reported as 118 (units not provided). Historical drugs included "Prevair" in 2016. The patient's medical history was not provided. She had no drug reactions or allergies.  On 19-AUG-2020, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (lot#, expiration date, dose and route of administration were not reported) for prophylaxis. Since the day of vaccination, the patient had pain and soreness. She also reported that she could not lift her arm and had been loosing her balance since the shot area of injection was still sore and swollen. The patient did not seek medical attention and no treatment was given for the events. No laboratory diagnostic was performed. The outcome of all events was reported as not recovered/not resolved. The relatedness between the events and pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was not reported.
The following morning developed rapid onset of memory loss. Transported to ER, urgent ct performed with contrast. No findings and diagnosed with Transient Global Amnesia   Resolved within 4 hours
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  HYPOTENSION  5/10/2022 --  RECURRENCE OF SAME SYMPTOMS
Patient developed fever greater than 102 degrees F in less than 18 hours post vaccination.  Associated with fever child developed jerking movements of arms and legs and body. Child irritable after jerking episode, lasting less than 15 minutes.  Treatment: Fever monitoring and reduced pain.
On February 12, I began to get a rash on my back which spread quickly to my torso and arms.  On February 20th went to walk in clinic - recived 4mg prednisone for 6 days.  Rash continued to spread over upper leg. March 2nd returned to clinic and was prescribed 20mg prednisone for 12 days, plus triamcinolone cream.  Medicine did not help rash and it continued to spread to stomach. When asked if I should get the second dose, the dr at the clinic said yes get second dose.  March 3rd recieved second COVID shot.  March 26th saw Dermatologist she perrformed skin biopsy and said to continue triamcinolone cream plus Eucerin lotion.  Biopsy showed hypersenistive reaction and
no adverse event happen. Patient received the vaccine toward the back of the arm instead of the deltoid muscle due to technician thought we cannot give it over tattoo.
flu-like symptoms reported by some patients; expired vaccine was administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered) and INFLUENZA LIKE ILLNESS (flu-like symptoms reported by some patients) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms reported by some patients). On 04-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms reported by some patients) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter provided below information: - Number of doses/vials: 63 doses, 3-4 vials - Date the vial was initially stored in the refrigerator*: 1DEC2021 - Did the vial undergo any temperature excursions*? No No concomitant medication reported. No treatment medication details reported.   This case was linked to MOD-2022-449480 (Patient Link).
No additional adverse events reported; The caller stated that the patient(full demographics not provided) is due for his 3rd GARDASIL 9 shot today, 04/10/2020 and has not received it; This spontaneous report was received from a patient's wife referring to a male patient of unknown age.  The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided.     On unknown dates, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) dose 1 and dose 2 (dose detail, frequency, route, lot# and expiration date were not reported) for prophylaxis. On 10-APR-2020, the patient was due for his 3rd hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) shot and had not received it (inappropriate schedule of product administration). No additional adverse events were reported.
Moderna COVID-19 Vaccine EUA significant all over body hives appeared a few days after the vaccination, and are gradually getting better.  2 weeks past vaccination and Right Arm is still broken out and pimples near the injection site, about the size of a softball.  other areas include inside both arms, both elbows, tummy near belly button,  under nipples, neck and collarbone, forehead.  This just sucks.
My child received 2 doses of the GARDASIL vaccine. After the 1st dose she developed amenorrhea over 3 months, and after the second vaccine she developed amenorrhea again. She is now being seen by gynecologist and endocrinologist for this issue. My child had normal menstrual cycles before this vaccination.
BLOOD IN STOOL; STOMACH PAIN LIKE A CUT INSIDE; FREQUENT BATHROOM VISITS THREE TIMES IN A ROW; This spontaneous report received from a patient concerned a 44 year old Hispanic or Latino male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: 25-MAY-2021) dose was not reported, once total, administered on 27-MAR-2021 at Left Arm as prophylactic vaccination. No concomitant medications were reported.  On 11-Apr-2021, the patient experienced blood in stool (bleeding in feces). It was reported that bleeding was almost like hemorrhage, a lot of blood came out and patient felt like patient was bleeding internally. Patient described pain like stomach was cut inside. The patient felt bad on the side of his stomach all over midsection. He mentioned that it started all of sudden, on same day an hour later he went to the restroom and went 3 times after in a row, on the day of report patient did not use the restroom and the pain was less. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from frequent bathroom visits three times in a row on 13-APR-2021, was recovering from stomach pain like a cut inside, and had not recovered from blood in stool. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210426962-covid-19 vaccine ad26.cov2.s-Blood in stool. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
MUSCLE ACHES; FEVER; RASH; HEADACHE; This spontaneous report received from a patient concerned a 65 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included latex allergy, and ciprofloxacin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 11:00 for prophylactic vaccination. Concomitant medications included levothyroxine sodium. On APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced rash. On 10-APR-2021, the subject experienced muscle aches. On 10-APR-2021, the subject experienced fever. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rash on 11-APR-2021, and muscle aches, and fever on APR-2021, and had not recovered from headache. This report was non-serious.
Redness,swelling and itching   of 5cm radius to injection site 7 days after taking the 1st dose of vaccine at approximately 8:30 AM.Given keflex 500mg twice daily for 10days.Instructed to apply ice to reddened area as needed.
The patient experienced syncope within 30 minutes after receiving the covid-19 vaccine. At 2:30pm, she felt dizziness, her head was spinning, weakness of the arms, and slurred speech. Her FS was at 108 (Normal), BP 195/105 (Extremely high), Pulse 91, O2 saturation was at 100%. At 2:48PM, her BP lowered to 167/92. At this time, she can smile, she can put her hands up, she can kick her feet and she can opened/closed her eyes. Due to her high BP, Doctor requested that the should go to the ER via the ambulance.
Hot to Touch Sensation - Near Injection Site; Itchy Sensation - Near Injection Site; Redness - Near Injection Site; Swelling - Near Injection Site; Rash - Near Injection Site; Arm Soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Soreness), VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Soreness). On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE RASH (Rash - Near Injection Site). On 12-Feb-2021, PAIN IN EXTREMITY (Arm Soreness) had resolved. At the time of the report, VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE RASH (Rash - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included cefalexin, advised by HCP to try and help alleviate the symptoms.
The following day after the vaccine my mother began to have severe headaches that were every day and would last all day long. At first she thought it was a sinus infection but that was ruled out by her ENT.  Her PCP put her on typical tension headache meds like OTC Advil  or Tylenol and gave her a muscle relaxer.  None of these helped. The was no relief at all.  She decided to see a Chiropractor with no relief from that either. In the meantime she was also seeing a Neurologist who wasn't helping and so she switched to a new one. The new Neurologist  has put her on every medication known for headaches/migraines with no relief. Of course this went on for over a year switching all the medications to see which one would work. She has also tried massage therapy and Acupuncture which she has not gotten relief from this either, but is still trying with this. At this point as of 6/2023 after 27 months of all kinds of medications and treatments she is still in severe pain everyday and now the Neurologist has suggested a spinal tap.
feeling tight in my lungs; feel tired; spacy; body aches; my limbs felt heavy; gastrointestinal issues; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 50-year-old female patient received the second dose of BNT162B2 (lot number: Ek4176), via an unspecified route of administration on 13Jan2021 08:00 in right arm at single dose for COVID-19 immunization. Medical history included asthma, thyroid cancer, thyroidectomy, attention deficit hyperactivity disorder (ADHD), and known allergies: Penicillin. Concomitant medications included levothyroxine sodium (SYNTHROID), paracetamol (TYLENOL), salbutamol (ALBUTEROL HFA), budesonide/formoterol fumarate (SYMBICORT), and tiotropium bromide (SPIRIVA). The patient previously took azithromycin (ZPACK), and benzonatate and experienced drug allergy, and first dose of BNT162B2 (lot number: EJ1685) on 23Dec2020 08:00 in arm for COVID-19 immunization. The patient experienced feeling tight in lungs 45 min after on 13Jan2021 09:00, it lasted approximately 30 minutes. Around 3-4 hours after started to feel tired, spacy and body aches. Her limbs felt heavy, and gastrointestinal issues, nausea (ondansetron (ZOFRAN) took care of that issue) no vomiting on 13Jan2021, was brought home from work. And slept for 3 hours. Woke up and have continued body aches. The patient underwent lab tests and procedures which included nasal swab: negative on 04Jan2021. Therapeutic measures were taken as a result of nausea. Outcome of event body aches was not resolved and of other events was unknown.
Injection site red, swollen, painful to touch, itchy, hot to touch. Prescribed cephalexin 250 mg - 1 tsp BID.
Weakness, tiredness, joint fatigue.  2 days worth.  Needed to bed first day. Note:  I have morning coffee with three other seniors.  We all bad the second booster at seperate locations on the same week.  We all had adverse reactions from the second booster.  For what it's worth, we are reasonably healthy for our ages (73-82).  All of us are capable of walking 5 miles or more per day.  We are all retired upper-middle class professionals.
100.2 fever- 5 hours Body aches- 8 hours Fatigue- 12 hours Painful injection site with large rash- ongoing
No symptoms or additional adverse effects reported; received unspecified dose in PROQUAD that was improperly stored; This spontaneous report was received from a nurse and refers to a patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 08-JUL-2020, the patient was vaccinated with dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, lot # S021328, expiration date 05-JAN-2021 (strength, route of administration and dose were not reported) reconstituted in properly stored sterile diluent, for prophylaxis.  On an unknown date, the dose of the vaccine was exposed to temperature excursion at 67 Fahrenheit (F) degrees for 17 hours. There was no previous temperature excursion. The call was due to digital data logger. No symptoms or additional adverse effects reported.
nausea and dizziness. Waited extra 15 mins and given OJ. Pt self administered glucose tabs. Evaluated by EMS-Cleared
Blurred vision, drooping and decreased sensation of left side of face, eyes feel heavy and swollen.
Immunizations for Immigration given 2/23/2000. On 2/25/2000, PM, Started itching of hand and feet with swelling. Rubbed lotion on them and ran in cool water. On 2/26/2000, AM, swelling and rash of hands and feet had increased and eyes were swollen, especially on right side. Progressed up legs to stomach and back. On 2/27/2000, some itching of roof of mouth. Took Sine-eez (over the counter). Complains of mild headache beginning 2/26 and continuing. Seen in HD on 2/28/2000, some swelling of hands and around eyes remains and occasional itching.
headache when bending down lower then waist that feels like pulsing in front of head by hairline; pressure feeling on top of teeth; coldness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (coldness), DISCOMFORT (pressure feeling on top of teeth) and HEADACHE (headache when bending down lower then waist that feels like pulsing in front of head by hairline) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034FZ1A, 031L20A and 011220A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING COLD (coldness). On 08-Dec-2021, the patient experienced DISCOMFORT (pressure feeling on top of teeth). On 08-Dec-2021 at 3:45 AM, the patient experienced HEADACHE (headache when bending down lower then waist that feels like pulsing in front of head by hairline). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) on 08-Dec-2021 at a dose of 1 dosage form twice a day. At the time of the report, FEELING COLD (coldness), DISCOMFORT (pressure feeling on top of teeth) and HEADACHE (headache when bending down lower then waist that feels like pulsing in front of head by hairline) outcome was unknown.            This case was linked to MOD-2021-407141 (Patient Link).
Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023; No adverse event; She had expired vaccine that was administered on 15-Mar-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on 15-Mar-2023), PRODUCT STORAGE ERROR (Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023) and NO ADVERSE EVENT (No adverse event) in a 33-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 060B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on 15-Mar-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on 15-Mar-2023), PRODUCT STORAGE ERROR (Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on 15-Mar-2023) and PRODUCT STORAGE ERROR (Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023).    It was unknown if the patient was ever diagnosed with or tested positive for COVID-19.  Concomitant medications of the patient were not reported.  The vial was initially stored in the refrigerator on 14-Mar-2023. The vial did not undergo any temperature excursions.  HCP stated that expired Moderna COVID-19 monovalent vaccine was administered to approximately 75-125 patients on 15-Mar-2023. There was potentially a second lot number that was expired and was administered to patients on 03-Mar-2023, but HCP did not have any details on this event at the time of reporting.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-716065 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716065:Master case
Arm sore to the touch; Felt sluggish; This spontaneous case was reported by an other caregiver and describes the occurrence of PAIN IN EXTREMITY (Arm sore to the touch) and SLUGGISHNESS (Felt sluggish) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included CARVEDILOL, TAMSULOSIN, LISINOPRIL and APIXABAN (ELIQUIS) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm sore to the touch) and SLUGGISHNESS (Felt sluggish). At the time of the report, PAIN IN EXTREMITY (Arm sore to the touch) and SLUGGISHNESS (Felt sluggish) outcome was unknown.            No treatment information were reported   This case was linked to MOD-2021-029940, MOD-2021-030271, MOD-2021-030014 (Patient Link).
Suicidality, new onset major depression, generalized anxiety, aboulia and cognitive changes gradually increasing around 6 months after vaccination to highest severity by late July 2021.
Vomiting. Diarrhea. No fever. Endurated x 4 days. Reported no contact with anyone with similar symptoms. No new foods or no outside.
Itchy skin - eyes, lips, nose, chest  Tingling skin - cheeks Slight swelling - eyes, lips, ears
1 week after ENGERIX B injection pain (L) shoulder trouble with range of motion.
Patient was scheduled for Rabies vaccine (RABAVERT) but was given Typhim instead. Patient already had Typhim on 9/12/23 and was given a second dose today 9/21/23 instead of the Rabies vaccine.  Reached out to patient 6 hours later and patient only has injection site reactions.
Delayed response between 12 - 24 hours after vaccination.  Headache, muscle aches, extreme fatigue, shivering alternating with feeling feverish.  Already had COVID (estimated to be between 2 to 3 months ago).